Time-dependent effects of CX3CR1 in a mouse model of mild traumatic brain injury.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4557842)

Published in J Neuroinflammation on September 02, 2015

Authors

Heidi Y Febinger1,2, Hannah E Thomasy1,3, Maria N Pavlova1, Kristyn M Ringgold1, Paulien R Barf1, Amrita M George1, Jenna N Grillo1,4, Adam D Bachstetter5, Jenny A Garcia6, Astrid E Cardona6, Mark R Opp1, Carmelina Gemma7

Author Affiliations

1: Department of Anesthesiology and Pain Medicine, University of Washington, BOX # 359724, Seattle, WA, 98001, USA.
2: Present address: Interdepartmental Program in Neuroscience, University of Utah School of Medicine, Salt Lake City, Utah, USA.
3: Neuroscience Graduate Program, University of Washington, Seattle, WA, 98104, USA.
4: Department of Biology, University of Washington, Seattle, WA, 98104, USA.
5: Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY, 40536, USA.
6: Department of Biology and South Texas Center for Emerging Infectious Diseases, University of Texas at San Antonio, San Antonio, TX, 78249, USA.
7: Department of Anesthesiology and Pain Medicine, University of Washington, BOX # 359724, Seattle, WA, 98001, USA. cgemma@u.washington.edu.

Articles cited by this

Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53

Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56

The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol (2000) 14.74

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51

Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec (1991) 11.44

Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci (2006) 8.25

Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med (2007) 7.87

Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci (2009) 6.93

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A (1998) 5.15

Inflammation in neurodegenerative disease--a double-edged sword. Neuron (2002) 4.95

Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell (2010) 4.30

Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (1997) 3.74

Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation (2008) 3.69

Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol (2011) 3.42

Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest (2003) 3.19

Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol (2009) 3.04

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat Neurosci (2010) 2.79

Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol (2009) 2.46

Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis (2009) 2.44

Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J Cereb Blood Flow Metab (2008) 2.33

Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett (1998) 2.30

CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models. Am J Pathol (2010) 2.25

Regulation of tau pathology by the microglial fractalkine receptor. Neuron (2010) 2.24

Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation (2006) 2.23

Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener (2009) 2.23

Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci U S A (2000) 2.20

The role of markers of inflammation in traumatic brain injury. Front Neurol (2013) 2.01

The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol (2011) 1.96

CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci (2011) 1.95

CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-β phagocytosis. J Neurosci (2010) 1.88

Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res (2003) 1.87

Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro. Brain Behav Immun (2013) 1.66

Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci (2013) 1.65

The multifaceted profile of activated microglia. Mol Neurobiol (2009) 1.65

Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. J Cereb Blood Flow Metab (2013) 1.62

Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages. J Neurosci (2011) 1.59

Chemokines and chemokine receptors: multipurpose players in neuroinflammation. Int Rev Neurobiol (2007) 1.56

Isolation of brain and spinal cord mononuclear cells using percoll gradients. J Vis Exp (2011) 1.40

CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem (2011) 1.40

Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res (2002) 1.32

Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J Neuroimmunol (2005) 1.30

CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci (2011) 1.29

Microglia activation as a biomarker for traumatic brain injury. Front Neurol (2013) 1.23

The effect of injury severity on behavior: a phenotypic study of cognitive and emotional deficits after mild, moderate, and severe controlled cortical impact injury in mice. J Neurotrauma (2012) 1.20

Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration. Front Pharmacol (2012) 1.20

Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats. J Neurosci (2001) 1.17

CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice. Glia (2013) 1.17

CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury. J Neurosci (2015) 1.12

Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse. J Neurotrauma (2012) 1.12

The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention. J Neuroinflammation (2012) 1.12

CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke. J Neuroinflammation (2014) 0.99

Synergistic stimulation, by tumor necrosis factor-alpha and interferon-gamma, of fractalkine expression in human astrocytes. Neurosci Lett (2001) 0.96

The chemokine fractalkine in patients with severe traumatic brain injury and a mouse model of closed head injury. J Cereb Blood Flow Metab (2004) 0.96

Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation. J Immunol (2013) 0.95

Bone marrow mesenchymal stromal cells drive protective M2 microglia polarization after brain trauma. Neurotherapeutics (2014) 0.91

Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-Egfp-ki mouse model. J Neuroimmunol (2013) 0.83

Immunohistohemical expression of the chemokine fractalkine and its receptor in the human brain cortex after severe traumatic brain injury and brain hemorrhage. J Neurosurg Sci (2013) 0.78